We have located links that may give you full text access.
COMPARATIVE STUDY
JOURNAL ARTICLE
Eyelid lesions: incidence and comparison of benign and malignant lesions.
Annals of Ophthalmology 1985 November
A retrospective study was undertaken to determine the relative incidence of all eyelid lesions (720 cases) submitted to the Wills ophthalmic pathology laboratory between July 1, 1980, and June 30, 1982. Data on age, sex, location, and diagnostic accuracy were also tabulated. One hundred twenty-five (17.4%) malignant lesions were found. The most common lesion of the eyelid was basal cell carcinoma, which represented 14.3% of the total and 82.4% of the malignant lesions. Differences between malignant and benign lesions were searched for. The data suggests that lesions occurring in the upper lid are much less likely to be malignant than those occurring elsewhere. Among the 125 malignant lesions, clinicians were 92.8% accurate in predicting malignancy.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app